These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15272132)

  • 21. Infarct Volume Prediction by Early Magnetic Resonance Imaging in a Murine Stroke Model Depends on Ischemia Duration and Time of Imaging.
    Leithner C; Füchtemeier M; Jorks D; Mueller S; Dirnagl U; Royl G
    Stroke; 2015 Nov; 46(11):3249-59. PubMed ID: 26451016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Signal evolution and infarction risk for apparent diffusion coefficient lesions in acute ischemic stroke are both time- and perfusion-dependent.
    An H; Ford AL; Vo K; Powers WJ; Lee JM; Lin W
    Stroke; 2011 May; 42(5):1276-81. PubMed ID: 21454821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Initial ischemic event: perfusion-weighted MR imaging and apparent diffusion coefficient for stroke evolution.
    Seitz RJ; Meisel S; Weller P; Junghans U; Wittsack HJ; Siebler M
    Radiology; 2005 Dec; 237(3):1020-8. PubMed ID: 16237134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with diffusion-perfusion mismatch on magnetic resonance imaging 48 hours or more after stroke symptom onset: clinical and imaging features.
    Perez A; Restrepo L; Kleinman JT; Barker P; Beauchamp N; Wityk RJ
    J Neuroimaging; 2006 Oct; 16(4):329-33. PubMed ID: 17032382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance angiography-diffusion mismatch reflects diffusion-perfusion mismatch in patients with hyperacute cerebral infarction.
    Deguchi I; Dembo T; Fukuoka T; Nagoya H; Maruyama H; Kato Y; Ohe Y; Horiuchi Y; Uchino A; Tanahashi N
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):334-9. PubMed ID: 22005037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing tissue fate after transient cerebral ischemia of varying duration using quantitative diffusion and perfusion imaging.
    Bardutzky J; Shen Q; Henninger N; Schwab S; Duong TQ; Fisher M
    Stroke; 2007 Apr; 38(4):1336-44. PubMed ID: 17322082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis.
    Loh PS; Butcher KS; Parsons MW; MacGregor L; Desmond PM; Tress BM; Davis SM
    Stroke; 2005 Dec; 36(12):2626-31. PubMed ID: 16269645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed decompressive surgery increases apparent diffusion coefficient and improves peri-infarct perfusion in rats with space-occupying cerebral infarction.
    Hofmeijer J; Schepers J; Veldhuis WB; Nicolay K; Kappelle LJ; Bär PR; van der Worp HB
    Stroke; 2004 Jun; 35(6):1476-81. PubMed ID: 15131314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol.
    Ribo M; Molina CA; Rovira A; Quintana M; Delgado P; Montaner J; Grivé E; Arenillas JF; Alvarez-Sabín J
    Stroke; 2005 Mar; 36(3):602-6. PubMed ID: 15692107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion- and perfusion-weighted MR imaging.
    Na DG; Kim EY; Ryoo JW; Lee KH; Roh HG; Kim SS; Song IC; Chang KH
    Radiology; 2005 Jun; 235(3):992-48. PubMed ID: 15860675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of diffusion and perfusion deficits in patients with small subcortical ischemia.
    Doege CA; Kerskens CM; Romero BI; Brunecker P; Junge-Hülsing J; von Pannwitz W; Müller B; Villringer A
    AJNR Am J Neuroradiol; 2003 Aug; 24(7):1355-63. PubMed ID: 12917127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of tissue viability using diffusion- and perfusion-weighted MRI in hyperacute stroke.
    Moon WJ; Na DG; Ryoo JW; Roh HG; Byun HS; Chon YH; Chung EC
    Korean J Radiol; 2005; 6(2):75-81. PubMed ID: 15968145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infarct volume on apparent diffusion coefficient maps correlates with length of stay and outcome after middle cerebral artery stroke.
    Engelter ST; Provenzale J; Petrella JR; DeLong DM; Alberts MJ
    Cerebrovasc Dis; 2003; 15(3):188-91. PubMed ID: 12646778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke.
    Kosior RK; Wright CJ; Kosior JC; Kenney C; Scott JN; Frayne R; Hill MD
    Cerebrovasc Dis; 2007; 24(4):361-8. PubMed ID: 17690549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting final infarct size using acute and subacute multiparametric MRI measurements in patients with ischemic stroke.
    Lu M; Mitsias PD; Ewing JR; Soltanian-Zadeh H; Bagher-Ebadian H; Zhao Q; Oja-Tebbe N; Patel SC; Chopp M
    J Magn Reson Imaging; 2005 May; 21(5):495-502. PubMed ID: 15834917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.